The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Blood Glucose Device-Global Market Insights and Sales Trends 2024
Synopsis
The global Blood Glucose Device market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Blood Glucose Device in various end use industries. The expanding demands from the Hospitals, Diagnostics, Home Settings and Others, are propelling Blood Glucose Device market. Blood Glucose Monitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Glucose Monitoring Strips segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Glucose Device, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Glucose Device market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Glucose Device market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Glucose Device sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Glucose Device covered in this report include Abbott Laboratories (U.S.), ARKRAY (Japan), Dexcom (U.S.), F.Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (U.S.), Medtronic (U.S.), Nipro Diagnostics (U.S.) and Terumo Medical Corporation (U.S.), etc.
The global Blood Glucose Device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories (U.S.)
ARKRAY (Japan)
Dexcom (U.S.)
F.Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson (U.S.)
Medtronic (U.S.)
Nipro Diagnostics (U.S.)
Terumo Medical Corporation (U.S.)
Global Blood Glucose Device market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Glucose Device market, Segment by Type:
Blood Glucose Monitors
Glucose Monitoring Strips
Lancets
Global Blood Glucose Device market, by Application
Hospitals
Diagnostics
Home Settings
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Blood Glucose Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Blood Glucose Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Blood Glucose Device market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Blood Glucose Device in various end use industries. The expanding demands from the Hospitals, Diagnostics, Home Settings and Others, are propelling Blood Glucose Device market. Blood Glucose Monitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Glucose Monitoring Strips segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Glucose Device, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Glucose Device market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Glucose Device market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Glucose Device sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Glucose Device covered in this report include Abbott Laboratories (U.S.), ARKRAY (Japan), Dexcom (U.S.), F.Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (U.S.), Medtronic (U.S.), Nipro Diagnostics (U.S.) and Terumo Medical Corporation (U.S.), etc.
The global Blood Glucose Device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories (U.S.)
ARKRAY (Japan)
Dexcom (U.S.)
F.Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson (U.S.)
Medtronic (U.S.)
Nipro Diagnostics (U.S.)
Terumo Medical Corporation (U.S.)
Global Blood Glucose Device market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Glucose Device market, Segment by Type:
Blood Glucose Monitors
Glucose Monitoring Strips
Lancets
Global Blood Glucose Device market, by Application
Hospitals
Diagnostics
Home Settings
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Blood Glucose Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Blood Glucose Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Blood Glucose Device Market Overview
1.1 Blood Glucose Device Product Overview
1.2 Blood Glucose Device Market Segment by Type
1.2.1 Blood Glucose Monitors
1.2.2 Glucose Monitoring Strips
1.2.3 Lancets
1.3 Global Blood Glucose Device Market Size by Type
1.3.1 Global Blood Glucose Device Market Size Overview by Type (2018-2029)
1.3.2 Global Blood Glucose Device Historic Market Size Review by Type (2018-2023)
1.3.3 Global Blood Glucose Device Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Blood Glucose Device Sales Breakdown by Type (2018-2023)
1.4.2 Europe Blood Glucose Device Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Blood Glucose Device Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Blood Glucose Device Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Blood Glucose Device Sales Breakdown by Type (2018-2023)
2 Global Blood Glucose Device Market Competition by Company
2.1 Global Top Players by Blood Glucose Device Sales (2018-2023)
2.2 Global Top Players by Blood Glucose Device Revenue (2018-2023)
2.3 Global Top Players by Blood Glucose Device Price (2018-2023)
2.4 Global Top Manufacturers Blood Glucose Device Manufacturing Base Distribution, Sales Area, Product Type
2.5 Blood Glucose Device Market Competitive Situation and Trends
2.5.1 Blood Glucose Device Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Blood Glucose Device Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Glucose Device as of 2022)
2.7 Date of Key Manufacturers Enter into Blood Glucose Device Market
2.8 Key Manufacturers Blood Glucose Device Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Blood Glucose Device Status and Outlook by Region
3.1 Global Blood Glucose Device Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Blood Glucose Device Historic Market Size by Region
3.2.1 Global Blood Glucose Device Sales in Volume by Region (2018-2023)
3.2.2 Global Blood Glucose Device Sales in Value by Region (2018-2023)
3.2.3 Global Blood Glucose Device Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Blood Glucose Device Forecasted Market Size by Region
3.3.1 Global Blood Glucose Device Sales in Volume by Region (2024-2029)
3.3.2 Global Blood Glucose Device Sales in Value by Region (2024-2029)
3.3.3 Global Blood Glucose Device Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Blood Glucose Device by Application
4.1 Blood Glucose Device Market Segment by Application
4.1.1 Hospitals
4.1.2 Diagnostics
4.1.3 Home Settings
4.1.4 Others
4.2 Global Blood Glucose Device Market Size by Application
4.2.1 Global Blood Glucose Device Market Size Overview by Application (2018-2029)
4.2.2 Global Blood Glucose Device Historic Market Size Review by Application (2018-2023)
4.2.3 Global Blood Glucose Device Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Blood Glucose Device Sales Breakdown by Application (2018-2023)
4.3.2 Europe Blood Glucose Device Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Blood Glucose Device Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Blood Glucose Device Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Blood Glucose Device Sales Breakdown by Application (2018-2023)
5 North America Blood Glucose Device by Country
5.1 North America Blood Glucose Device Historic Market Size by Country
5.1.1 North America Blood Glucose Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Blood Glucose Device Sales in Volume by Country (2018-2023)
5.1.3 North America Blood Glucose Device Sales in Value by Country (2018-2023)
5.2 North America Blood Glucose Device Forecasted Market Size by Country
5.2.1 North America Blood Glucose Device Sales in Volume by Country (2024-2029)
5.2.2 North America Blood Glucose Device Sales in Value by Country (2024-2029)
6 Europe Blood Glucose Device by Country
6.1 Europe Blood Glucose Device Historic Market Size by Country
6.1.1 Europe Blood Glucose Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Blood Glucose Device Sales in Volume by Country (2018-2023)
6.1.3 Europe Blood Glucose Device Sales in Value by Country (2018-2023)
6.2 Europe Blood Glucose Device Forecasted Market Size by Country
6.2.1 Europe Blood Glucose Device Sales in Volume by Country (2024-2029)
6.2.2 Europe Blood Glucose Device Sales in Value by Country (2024-2029)
7 Asia-Pacific Blood Glucose Device by Region
7.1 Asia-Pacific Blood Glucose Device Historic Market Size by Region
7.1.1 Asia-Pacific Blood Glucose Device Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Blood Glucose Device Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Blood Glucose Device Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Blood Glucose Device Forecasted Market Size by Region
7.2.1 Asia-Pacific Blood Glucose Device Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Blood Glucose Device Sales in Value by Region (2024-2029)
8 Latin America Blood Glucose Device by Country
8.1 Latin America Blood Glucose Device Historic Market Size by Country
8.1.1 Latin America Blood Glucose Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Blood Glucose Device Sales in Volume by Country (2018-2023)
8.1.3 Latin America Blood Glucose Device Sales in Value by Country (2018-2023)
8.2 Latin America Blood Glucose Device Forecasted Market Size by Country
8.2.1 Latin America Blood Glucose Device Sales in Volume by Country (2024-2029)
8.2.2 Latin America Blood Glucose Device Sales in Value by Country (2024-2029)
9 Middle East and Africa Blood Glucose Device by Country
9.1 Middle East and Africa Blood Glucose Device Historic Market Size by Country
9.1.1 Middle East and Africa Blood Glucose Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Blood Glucose Device Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Blood Glucose Device Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Blood Glucose Device Forecasted Market Size by Country
9.2.1 Middle East and Africa Blood Glucose Device Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Blood Glucose Device Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Laboratories (U.S.)
10.1.1 Abbott Laboratories (U.S.) Company Information
10.1.2 Abbott Laboratories (U.S.) Introduction and Business Overview
10.1.3 Abbott Laboratories (U.S.) Blood Glucose Device Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Laboratories (U.S.) Blood Glucose Device Products Offered
10.1.5 Abbott Laboratories (U.S.) Recent Development
10.2 ARKRAY (Japan)
10.2.1 ARKRAY (Japan) Company Information
10.2.2 ARKRAY (Japan) Introduction and Business Overview
10.2.3 ARKRAY (Japan) Blood Glucose Device Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ARKRAY (Japan) Blood Glucose Device Products Offered
10.2.5 ARKRAY (Japan) Recent Development
10.3 Dexcom (U.S.)
10.3.1 Dexcom (U.S.) Company Information
10.3.2 Dexcom (U.S.) Introduction and Business Overview
10.3.3 Dexcom (U.S.) Blood Glucose Device Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Dexcom (U.S.) Blood Glucose Device Products Offered
10.3.5 Dexcom (U.S.) Recent Development
10.4 F.Hoffmann-La Roche Ltd (Switzerland)
10.4.1 F.Hoffmann-La Roche Ltd (Switzerland) Company Information
10.4.2 F.Hoffmann-La Roche Ltd (Switzerland) Introduction and Business Overview
10.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Revenue and Gross Margin (2018-2023)
10.4.4 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Products Offered
10.4.5 F.Hoffmann-La Roche Ltd (Switzerland) Recent Development
10.5 Johnson & Johnson (U.S.)
10.5.1 Johnson & Johnson (U.S.) Company Information
10.5.2 Johnson & Johnson (U.S.) Introduction and Business Overview
10.5.3 Johnson & Johnson (U.S.) Blood Glucose Device Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson & Johnson (U.S.) Blood Glucose Device Products Offered
10.5.5 Johnson & Johnson (U.S.) Recent Development
10.6 Medtronic (U.S.)
10.6.1 Medtronic (U.S.) Company Information
10.6.2 Medtronic (U.S.) Introduction and Business Overview
10.6.3 Medtronic (U.S.) Blood Glucose Device Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Medtronic (U.S.) Blood Glucose Device Products Offered
10.6.5 Medtronic (U.S.) Recent Development
10.7 Nipro Diagnostics (U.S.)
10.7.1 Nipro Diagnostics (U.S.) Company Information
10.7.2 Nipro Diagnostics (U.S.) Introduction and Business Overview
10.7.3 Nipro Diagnostics (U.S.) Blood Glucose Device Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Nipro Diagnostics (U.S.) Blood Glucose Device Products Offered
10.7.5 Nipro Diagnostics (U.S.) Recent Development
10.8 Terumo Medical Corporation (U.S.)
10.8.1 Terumo Medical Corporation (U.S.) Company Information
10.8.2 Terumo Medical Corporation (U.S.) Introduction and Business Overview
10.8.3 Terumo Medical Corporation (U.S.) Blood Glucose Device Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Terumo Medical Corporation (U.S.) Blood Glucose Device Products Offered
10.8.5 Terumo Medical Corporation (U.S.) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Blood Glucose Device Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Blood Glucose Device Industrial Chain Analysis
11.4 Blood Glucose Device Market Dynamics
11.4.1 Blood Glucose Device Industry Trends
11.4.2 Blood Glucose Device Market Drivers
11.4.3 Blood Glucose Device Market Challenges
11.4.4 Blood Glucose Device Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Blood Glucose Device Distributors
12.3 Blood Glucose Device Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
